.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 8,066,976

« Back to Dashboard

Claims for Patent: 8,066,976

Title:Foaming compositions for hair care
Abstract: The invention concerns a foaming composition for washing and treating hair and/or scalp essentially characterised in that it contains in an aqueous medium: at least an active principle selected among corticoids and retinoids; at least an anionic surfactant; at least an amphoteric surfactant; and a pro-penetrating agent.
Inventor(s): Preuilh; Isabelle (Le Cannet, FR), Guise; Anne-Emmanuelle (Rouen, FR), Willcox; Nathalie (Le Rouret, FR)
Assignee: Galderma S.A. (Cham, CH)
Application Number:12/724,620
Patent Claims: 1. A stable foaming composition for washing and treating hair and/or scalp characterized that it comprises: 0.05 wt % of clobetasol propionate, 2 to 25 wt % of sodium lauryl ether sulphate, 1 to 15 wt % of cocoyl betaine; 0.01 to 3 wt % of polyquaternium 10, 5 to 10 wt % of ethanol (95%-96%), citric acid and sodium citrate in an amount required to adjust the pH of said composition to between 5.5 and 6.5, and q.s. for 100% water.

2. A stable foaming composition for washing and treating hair and/or scalp characterized that it comprises: 0.01 and 0.3 wt % of an active ingredient selected from adapalene, 4-[7-(1-adamantyl)-6-methoxyethoxymethoxy-2-naphthyl]benzoic acid, 2-hydroxy-4-[3-oxo-3-(3-tert-butyl-4-methoxyphenyl)-1-propynyl]benzoic acid, 4-(3,5,5,8,8,-pentamethyl-5,6,7,8-tetrahydro-2-naphthylthio)benzoic acid and clobetasol 17-propionate, 2 to 25 wt % of sodium lauryl ether sulphate, 1 to 15 wt % of cocoyl betaine; 0.01 to 3 wt % of polyquaternium 10, 5 to 10 wt % of ethanol (95%-96%), citric acid and sodium citrate in an amount required to adjust the pH of said composition to between 5.5 and 6.5, and q.s. for 100% water.

3. The stable foaming composition of claim 1 wherein the ratio of the amount of sodium lauryl ether sulphate in said composition to the amount of cocoyl betaine in said composition is in the range of 1-20.

4. The stable foaming composition of claim 1 wherein the ratio of the amount of sodium lauryl ether sulphate in said composition to the amount of cocoyl betaine in said composition is 2 to 10.

5. The stable foaming composition of claim 1 wherein the ratio of the amount of sodium lauryl ether sulphate in said composition to the amount of ethanol in said composition is 1 to 2.

6. The stable foaming composition of claim 2 wherein the ratio of the amount of sodium lauryl ether sulphate in said composition to the amount of cocoyl betaine in said composition is in the range of 1-20.

7. The stable foaming composition of claim 2 wherein the ratio of the amount of sodium lauryl ether sulphate in said composition to the amount of cocoyl betaine in said composition is 2 to 10.

8. The stable foaming composition of claim 2 wherein the ratio of the amount of sodium lauryl ether sulphate in said composition to the amount of ethanol in said composition is 1 to 2.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc